CURRICULUM VITAE

MARK KENNETH ROBBINS, M.D.

I. Personal Data

Home Address: 160 Ivy Ridge RoadCharlottesville, Virginia 22901(434) 973-5896 Home(434) 981-7564 CellEmail: mkr3j2001@yahoo.com

II. Education

08/1979-06/1983 Bachelor of Arts, Biology, Gettysburg CollegeGettysburg, PennsylvaniaSumma Cum Laude, Phi Beta Kappa

08/1983-06/1987 Medical DoctorateUniversity of North Carolina School of MedicineChapel Hill, North Carolina

III. Residency and Fellowship Training

07/1987-06/1990 Resident I, II, III, Department of MedicineMilton S. Hershey Medical CenterPennsylvania State UniversityHershey, Pennsylvania

07/1991-07/1994 Pulmonary/Critical Care FellowDivision of Pulmonary MedicineUniversity of North Carolina School of MedicineChapel Hill, North Carolina

IV. Previous experience

07/1990-08/ 1991 Kron Medical07/1994-09/1994 Chapel Hill NC

Locum tenems internal medicine

09/1994-07/2011 Associate Professor of MedicineMedical Director, Lung TransplantMedical Director, Adult Cystic Fibrosis ClinicUniversity of Virginia Health Sciences CenterCharlottesville, Virginia

08/2011-08/2014 Augusta Medical centerFishersville, VirginiaStaff PhysicianPulmonary ICUMedical Director: Respiratory TherapyClinics in Bath County and Lexington VA

08/ 2014-present Weatherby HealthcareDurham NCPulmonary/ Critical care medicine- locum tenems

09/ 2014-present Comphealth Salt Lake City, UtahPulmonary/ Critical care medicine- locum tenems

10/2014-10/2015 Select Specialty HospitalEvansville INPulmonary- Critical care-locums tenems

11/2014-03/2015 Vibra Hospital of BoiseBoise IdahoPulmonary /Critical care- Locum tenems

03/2015-present Carilion New River Valley Medical CenterRadford Virginia 24141-0095Pulmonary-Critical care- Locum tenems

03/2015-present Vindant Hospital/ECU Medical CenterGreenville NC 27834Pulmonary -Critical care- Locum tenems

11/2015 Novant PresbyterianCharlotte NCPulmonary- Critical care Locum tenems

12/2015 Mary Washington HospitalFredricksburg VA

V. Certification & Licensure

American Board of Internal Medicine Initial 1990Re-certified 2000 expiration 2010 No. 130897Re-certified 2010 expiration 12/2020

Diplomate in Pulmonary Disease Initial 1994Re-certified 2000 Expiration 2014Re certified 2013 Expiration 12/2024 No. 130897

Diplomate in Critical Care Medicine Initial 1995Re-certified 2000 Expiration 2014 No. 130897Re-certified 2014 Expiration 12/2024

Commonwealth of Virginia License 9/15/94- 2/29/2016 No. 0101051676

Indiana State license 9/30/2014- 10/31/2015No 01074603A

Idaho State license 10/23/2014-6/30/2016 No. M -12688

North Carolina Medical Board 01/30/2015-02/25/2016 No. 39873

DEA License Exp 4/30/2016

Basic Life Support ( AHA) Exp 9/30/2016

Advanced Life Support Provider (AHA) Exp 9/30/2016

NPI 1790825628.

UPIN MEDICARE UPIN E88534

CAQH 12266685

VI. Professional Affiliations

American College of Chest PhysiciansAmerican Thoracic SocietyInternational Society of Heart & Lung TransplantVirginia Thoracic Society

VII. Award

Department of Medicine Clinical Excellence Award February 2000School of Medicine Award for Clinical Excellence March 2004

VIII. Completed ProjectsMedical Director Augusta Health: Respiratory TherapyChair, Critical Care Committee

IX. Teaching Activities

“Cystic Fibrosis: Care of the Adult Patient.” Medical Grand Rounds. University of Virginia Health Sciences Center, Charlottesville, Virginia. February 16, 1995.

“Evaluation for Lung Transplantation.” Challenges in Respiratory Care: Lung Transplantation. The Centerfor Organizational Development, University of Virginia Health Sciences Center, Charlottesville, Virginia.March 23, 1995.

“Update on Lung Transplantation.” Medical Grand Rounds. University of Virginia Health Sciences Center, Charlottesville, Virginia. October 5, 1995.

“Cystic Fibrosis.” Family Medicine Ground Rounds. University of Virginia Health Sciences Center, Charlottesville, Virginia. October 18, 1996.

“Transitioning to Adult Care.” University of Virginia Health System, Kluge Children’s Rehabilitation Center, 2nd Annual Cystic Fibrosis Family Day. Charlottesville, Virginia. November 15, 1997.

“Lung Transplantation at UVA: The First Decade.” Surgical Grand Rounds. University of Virginia Health System. Charlottesville, Virginia. February 17, 1999.

“Care of the Adult Cystic Fibrosis Patient.” Medical Grand Rounds. University of Virginia Health System. Charlottesville, Virginia. July 12, 1999.

X. Scientific Activities 

National Committees:

2000-2005 Cystic Fibrosis Center Committee: Provide site visits and evaluation of CF Centers.2003 OPTN/UNOS “Conference on Lung Allocation Policy”. Chicago, Illinois. July 2002-2004 Representative for Region 11 on OPTN/UNOS Thoracic Organ Transplant Committee.July 2010-June 2012 OPTN/UNOS Membership and Professional Standards Committee

XI. Publications

Papers:“Effect of Oxygen Breathing Following Submaximal and Maximal Exercise on Recovery and Performance.” Robbins MK, Gleeson K & Zwillich CW. Med Sci Sports Exer. 24:720-725, 1992.

“Cholelithoptysis: A Complication Following Laparoscopic Cholecystectomy.” Downie GH, Robbins MK, Souza JJ and Paradowski L. Chest. 103:616-617, 1993.

“Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis.” Crews Jr. WD, Jefferson AL, Broshek DK, Barth JT & Robbins MK. Archives of Clinical Neuropsychology, Vol. 15, No. 1. 2000.

“A Neuropsychological Normative Database for Lung Transplant Candidates.” Ruchinskas RA, Broshek DK, Crews Jr. WD, Barth JT, Francis JP & Robbins MK. Journal of Clinical Psychology in Medical Settings,Vol 7, No. 2. 2000.

“Neuropsychological Dysfunction in Patients Suffering from End-Stage Chronic Obstructive Pulmonary Disease.” Crews Jr. WD, Jefferson AL, Bolduc TA, Elliott JB, Ferro NM, Broshek DK, Barth JT & Robbins MK. Archives of Clinical Neuropsychology. 16 (2001) 643-652.

“Influence of Graft Ischemic Time on Outcomes Following Lung Transplantation.” Fiser SM, Kron IL, Long SM, Kaza AK, Kern JA, Cassada DC, Jones DR, Robbins, MK, Tribble CG. Journal of Heart Lung Transplant. Dec. 2001 20(12):1291-1296.

“Donor Lung Salvage After Neurogenic Pulmonary Edema With the Use of Post-Transplant Extracorporeal Membrane Oxygenation.” Fiser SM, Kron IL, Long SM, Kaza AK, Robbins MK, Kern JA, Tribble CG.Journal of Thoracic and Cardiovascular Surgery, Dec. 2001; 122(6):1257-1258.

“Coronary Risk Stratification in Patients With End-Stage Lung Disease.” Kaza AK, Dietz JF, Kern JA, Jones DR, Robbins MK, Fiser SM, Long SM, Bergin JD, Kron IL, Tribble CG. Journal of Heart Lung Transplant. 2002 Mar; 21(3):334-9.

“Ischemia-Reperfusion Injury After Lung Transplantation Increases Risk of Late Bronchiolitis Obliterans Syndrome.” Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, Robbins MK, Kron IL. Annals of Thoracic Surgery. 2002 Apr; 73(4):1041-7; discussion 1047-8.

“An Examination of the Neuropsychological Sequelae Associated with End-Stage Pulmonary Disease Secondary to Alpha-1-Antitrypsin Deficiency.” Jefferson AL, Crews Jr. WD, Broshek DK, Barth JT & Robbins MK. Advances in Medical Psychotherapy & Psychodiagnostics, 11, 35-43. 2002.

“Mucormycosis of the Bronchial Anastomosis: A Case of Successful Medical Treatment and Historic Review.” McGuire FR, Grinnan DC, Robbins MK. The Journal of Heart and Lung Transplantation, August 2007.

“Lung Transplantation in Patients 60 Years and Older: Results, Complications, and Outcomes.” Smith, PW, Wang H, Parini V, Zolak JS, Shen KR, Daniel TM, Robbins MK, Tribble CG, Kron IL, Jones DR. Annual Thoracic Surgery, 2006 Nov; 82 (5): 1835-41; discussion 1841.

“Posttransplantation Lypohoproliferative Disease Involving the Pituitary Gland,” Meriden Z, Bullock GC, Bragg A, Bonatti H, Cousar JB, Lopes MB, Robbins MK, Cathro HP. Human Pathology, 2010 Jul; 23.

Chapters:

“Lung Transplants.” Paradowski LJ, Robbins MK. Emergency Medicine. 4th Edition. Tintinalli JE. 1996.

“Inflammation and Cell Damage Induced by Repeated Exposure of Humans to Ozone.” Robbins MK. Inhalation Toxicology. Ed. Taylor & Francis.

“Pulmonology.” Chang A, Koenig S, Robbins MK. Medicine Recall. Bergin JD. 1997.

“Endocrine and Renal Disorders in Cystic Fibrosis.” Robbins MK., Ontjes DA. Cystic Fibrosis in Adults. Yankaskas JR & Knowles MR. 1999.

“Pulmonary Disease and Lung Transplantation.” Broshek, Donna K., Shaver, George W., & Robbins, Mark K.

Neurovascular Neuropsychology. Ed. Festa, J. R, Lazar, R. M., 2009

Abstracts:

“Particle-Cell Interactions in the Human Lung.” Lay JC, Bennett WD, Gerrity TR, Devlin R, Robbins MK & Biscardi F. Journal of Aerosol Medicine 9th Congress. 1993.

“Nutritional Status of Cystic Fibrosis Patients Before and After Lung Transplantation.” Robbins MK, Paradowski L & Thompson J. AM Rev Respir Dis (suppl). 147:A30. 1993.

“Attenuation of Cellular and Biochemical Changes in the Lungs of Humans Exposed to Ozone for Five Days.” Devlin RB, Folinsbee LJ, Biscardi F, Becker S, Madden M, Robbins MK, & Koren HS. Am Rev Respir Dis (suppl). 147:A71. 1993.

“Effects of Nutritional Status of Cystic Fibrosis Patients on Lung Transplantation.” Robbins MK, Paradowski L & Thompson J. Pediatric Pulmonary (suppl). 9:273. 1993.

“Pain in CF Patients: A Contractural Approach.” Robbins MK, Chastain D, Eksterowicz N, & Wilmoth D. Pediatric Pulmonary (suppl). 9:326. 1997.

“Reductive Pathways for Nitrogen in the Cystic Fibrosis Airway: Clinical Implications.” Gaston B, Canady R, Robbins MK, Goldberg J. Pediatric Pulmonary (suppl). #468. 1998.

“Neuropsychological Functioning in Lung Transplant Candidates with Cystic Fibrosis.” Crews Jr. WD, Jefferson AL, Broshek DK, Barth JT, Robbins MK. Pediatric Pulmonary (suppl). #662. 1998.

“Impact of Chronic Pain in Adults with CF.” Chastain DC, Seymour T, Robbins MK. Pediatric Pulmonary (suppl). #663. 1998.

“Neuropsychological Dysfunction in Patients with End-Stage Pulmonary Disease: Lung Transplantation Evaluation.” Crews Jr. WD, Jefferson AL. Broshek DK, Rhodes RD, Williamson J, Brazil A, Barth JT, & Robbins MK. National Academy of Neuropsychology, San Antonio, TX. November 1999.

“Effects of Aerosolized S-Nitrosogluthathione in Cystic Fibrosis: A Preliminary Study.” Snyder A, Gaston B, Hunt J, Robbins MK. Pediatric Pulmonary (suppl). #254. 2000.

“Lung Transplantation for End-Stage Sarcoidosis: An Effective Treatment Strategy.” Robbins MK, Ryan BJ, Jones DR. Chest (suppl). Vol. 122/Number 4. # 795. October 2002.

“Bronchial Anastamotic Stenoses Following Lung Transplantation: Incidence and Treatment.” Aldalaan AM, Jones DR, Robbins MK, Matsumoto AH, Tribble CG, Kron, IL. Chest (suppl). Vol. 122/Number 4. #1095. October 2002.

“Patients Who Are Acidopenic Following Lung Transplantation Have Decreased Breath Condensate Levels of Ammonium.” Nguyen TA, Robbins MK, Jones D, Vaughan JW, Hunt JF, Gaston B. American Journal of Respiratory and Critical Care Medicine. Vol. 167, No 7. #A623. April 2003.

“Mycobacterium Tuberculosis Infection of the Mouth and Lower Gastrointestinal Tract Complicating Lung Transplantation.” Carswell JJ, Robbins MK. Chest. Vol 124/Number 4 (Suppl.) #256. October 2003.

“Successful Treatment of Mucormycosis Involving the Bronchial Anastomosis Following Lung Transplantation.” McGuire F, Grinnan D, Robbins MK. Poster, World Congress of Bronchology 2006, Abstract #114.

XII Invited Lectures

“Cholelithoptysis: A Complication Following Laparoscopic Cholecystectomy.” 58th Annual Scientific Assembly, ACCP Affiliates’ Forums. 1992.

“Osteoporosis in a Cystic Fibrosis Patient.” Adult Medicine Clinical Fellows Session (moderator). Seventh Annual North American Cystic Fibrosis Conference. 1993.

“Nutritional Status of Cystic Fibrosis Patients Before and After Lung Transplantation.” Transplantation Workshop. Seventh Annual North American Cystic Fibrosis Conference. 1993.

“Lung Transplantation.” Medical Grand Rounds. Wake Medical Center, Raleigh, North Carolina. April 1994.

“Nutritional Status of Cystic Fibrosis Patients Undergoing Lung Transplantation.” 5th Journees de Monaco. Cystic Fibrosis and Nutritional Problems. May 1994.

“Update on Lung Transplantation.” Grand Rounds. Chesapeake General Hospital, Chesapeake, Virginia. August 1995.

“Cystic Fibrosis, An Update.” Recent Advances in Clinical Medicine. University of Virginia Health Sciences Center, Charlottesville, Virginia. October 11, 1995.

“Osteoporosis in Patients with CF.” Roundtable Moderator. Ninth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Dallas, Texas. October 13, 1995.

“Update in Lung Transplant.” Medical Grand Rounds. Roanoke Memorial Hospital, Roanoke, Virginia. February 9, 1996.

“Diabetes in CF Children & Adults.” The Southeast CF Caregivers Conference. The Friday Center. Chapel Hill, North Carolina. May 31, 1996.

“Management of End-Stage Lung Disease.” Pulmonary Conference. West Virginia University, Morgantown, West Virginia. September 19, 1996.

“Update on Lung Transplantation.” Medicine Grand Rounds. West Virginia University, Morgantown, West Virginia. September 20, 1996.

“Medical Care of the Alpha 1 Patient.” Alpha 1 Support Group Picnic. The Williamsburg Hospitality House, Williamsburg, Virginia. October 19, 1996.

“Behavioral Contracting with CF Families.” The Tenth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Orlando, Florida. October 26, 1996.

“Osteoporosis in CF: Prevention & Treatment.” Workshop Co-Chairman. The Tenth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Orlando, Florida. October 26, 1996.

“Adult Issues: Enhancing Independence and Self Esteem.” The Eleventh Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Nashville, Tennessee. October 23, 1997.

“Panel: Adult Program Maturation.” The Eleventh Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Nashville, Tennessee. October 24, 1997.

“Primary Pulmonary Hypertension and Prostacyclin.” Recent Advances in Clinical Medicine. Charlottesville, Virginia. October 28, 1998.

“CF Pain Management/Substance Abuse.” The Southeast CF Caregivers Conference. The Friday Center. Chapel Hill, North Carolina. March 12, 1999.

“Non Medical Management of Advanced Lung Disease.” Virginia Association of Cardiovascular and Pulmonary Rehabilitation Annual Conference. Richmond, Virginia. March 20, 1999.

“Cystic Fibrosis: Treating the Adult with CF.” Virginia Pulmonary Conference. Virginia Thoracic Society. Richmond Virginia. October 2, 1999.

“Clinical Pathology Conference” Virginia Chapter Scientific Meeting. Roanoke, Virginia. March 11, 2000.

“Beyond Just Saying No---Smoking Cessation Strategies That Work.” Recent Advances in Clinical Medicine. Charlottesville, Virginia. October 26, 2000.

“Cystic Fibrosis Pharmacology.” Virginia Society of Health-System Pharmacists. Charlottesville, Virginia. April 5, 2001.

“Cystic Fibrosis.” Virginia Society of Health-System Pharmacists. The 2001 Fall Seminar. Norfolk, Virginia. September 21, 2001.

“Clinical Presentation of Lung Cancer.” Lung Cancer: Maximizing Technology and Therapy in the New Millennium. The Multidisciplinary Thoracic Oncology Program at the University of Virginia. Charlottesville, Virginia. November 17, 2001.

“Evaluation and Criteria for Listing, UNOS Listing.” Lung Transplantation in the New Millennium at the University of Virginia. Charlottesville, Virginia. February 28, 2003.

“Medical Alternatives to Lung Transplantation/Medical Management of the Lung Transplant Candidate.” Lung Transplantation in the New Millennium at the University of Virginia. Charlottesville, Virginia. February 28, 2003.

“CF Related Diabetes.” American Thoracic Society 2003, Postgraduate Course. Seattle, Washington.May 17, 2003.

“Lung Transplant: A New Allocation.” LifeNet 2nd Annual Transplant Physicians’ Dinner. Charlottesville, Virginia. March 15, 2004.

“The Adult Cystic Fibrosis Patient.” Medical Grand Rounds. University of Virginia Health System. Charlottesville, Virginia. July 2006.

“COPD: Nuts and Bolts.” Medical Grand Rounds. Carilion Roanoke Memorial Hospital. Roanoke, Virginia. October 6, 2006.

“Update on Lung Transplants.” The 2008 Virginia Society for Respiratory Care. The 31st Annual Symposium by the Sea. Virginia Beach, Virginia. May 14, 2008.